These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12951120)

  • 21. Amide-based derivatives of β-alanine hydroxamic acid as histone deacetylase inhibitors: attenuation of potency through resonance effects.
    Liao V; Liu T; Codd R
    Bioorg Med Chem Lett; 2012 Oct; 22(19):6200-4. PubMed ID: 22932316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potent histone deacetylase inhibitors: N-hydroxybenzamides with antitumor activities.
    Maeda T; Nagaoka Y; Kuwajima H; Seno C; Maruyama S; Kurotaki M; Uesato S
    Bioorg Med Chem; 2004 Aug; 12(16):4351-60. PubMed ID: 15265487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological evaluation of piperamide analogues as HDAC inhibitors.
    Luo Y; Liu HM; Su MB; Sheng L; Zhou YB; Li J; Lu W
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4844-6. PubMed ID: 21745740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histone deacetylase inhibitors.
    Hadjipavlou-Litina D
    Curr Pharm Des; 2008; 14(6):504. PubMed ID: 18336296
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis and biological evaluation of 2-, 3-, and 4-acylaminocinnamyl-N-hydroxyamides as novel synthetic HDAC inhibitors.
    Mai A; Massa S; Pezzi R; Valente S; Loidl P; Brosch G
    Med Chem; 2005 May; 1(3):245-54. PubMed ID: 16787320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and synthesis of non-hydroxamate histone deacetylase inhibitors: identification of a selective histone acetylating agent.
    Suzuki T; Matsuura A; Kouketsu A; Hisakawa S; Nakagawa H; Miyata N
    Bioorg Med Chem; 2005 Jul; 13(13):4332-42. PubMed ID: 15927839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase.
    Butler LM; Webb Y; Agus DB; Higgins B; Tolentino TR; Kutko MC; LaQuaglia MP; Drobnjak M; Cordon-Cardo C; Scher HI; Breslow R; Richon VM; Rifkind RA; Marks PA
    Clin Cancer Res; 2001 Apr; 7(4):962-70. PubMed ID: 11309347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and modeling of new benzofuranone histone deacetylase inhibitors that stimulate tumor suppressor gene expression.
    Charrier C; Clarhaut J; Gesson JP; Estiu G; Wiest O; Roche J; Bertrand P
    J Med Chem; 2009 May; 52(9):3112-5. PubMed ID: 19385600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aroyl-pyrrolyl hydroxyamides: influence of pyrrole C4-phenylacetyl substitution on histone deacetylase inhibition.
    Mai A; Massa S; Valente S; Simeoni S; Ragno R; Bottoni P; Scatena R; Brosch G
    ChemMedChem; 2006 Feb; 1(2):225-37. PubMed ID: 16892355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thiol-based SAHA analogues as potent histone deacetylase inhibitors.
    Suzuki T; Kouketsu A; Matsuura A; Kohara A; Ninomiya S; Kohda K; Miyata N
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3313-7. PubMed ID: 15149697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer network disruption by a single molecule inhibitor targeting both histone deacetylase activity and phosphatidylinositol 3-kinase signaling.
    Qian C; Lai CJ; Bao R; Wang DG; Wang J; Xu GX; Atoyan R; Qu H; Yin L; Samson M; Zifcak B; Ma AW; DellaRocca S; Borek M; Zhai HX; Cai X; Voi M
    Clin Cancer Res; 2012 Aug; 18(15):4104-13. PubMed ID: 22693356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1-Arylsulfonyl-5-(N-hydroxyacrylamide)tetrahydroquinolines as potent histone deacetylase inhibitors suppressing the growth of prostate cancer cells.
    Liu YM; Lee HY; Chen CH; Lee CH; Wang LT; Pan SL; Lai MJ; Yeh TK; Liou JP
    Eur J Med Chem; 2015 Jan; 89():320-30. PubMed ID: 25462248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2-(Phenylsulfonyl)quinoline N-hydroxyacrylamides as potent anticancer agents inhibiting histone deacetylase.
    Lee HY; Chang CY; Su CJ; Huang HL; Mehndiratta S; Chao YH; Hsu CM; Kumar S; Sung TY; Huang YZ; Li YH; Yang CR; Liou JP
    Eur J Med Chem; 2016 Oct; 122():92-101. PubMed ID: 27344487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amide analogues of TSA: synthesis, binding mode analysis and HDAC inhibition.
    Van Ommeslaeghe K; Elaut G; Brecx V; Papeleu P; Iterbeke K; Geerlings P; Tourwé D; Rogiers V
    Bioorg Med Chem Lett; 2003 Jun; 13(11):1861-4. PubMed ID: 12749885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benzimidazole and imidazole inhibitors of histone deacetylases: Synthesis and biological activity.
    Bressi JC; de Jong R; Wu Y; Jennings AJ; Brown JW; O'Connell S; Tari LW; Skene RJ; Vu P; Navre M; Cao X; Gangloff AR
    Bioorg Med Chem Lett; 2010 May; 20(10):3138-41. PubMed ID: 20392637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening of amide analogues of Trichostatin A in cultures of primary rat hepatocytes: search for potent and safe HDAC inhibitors.
    Fraczek J; Deleu S; Lukaszuk A; Doktorova T; Tourwé D; Geerts A; Vanhaecke T; Vanderkerken K; Rogiers V
    Invest New Drugs; 2009 Aug; 27(4):338-46. PubMed ID: 18825314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histone deacetylase inhibitors: assays to assess effectiveness in vitro and in vivo.
    Richon VM; Zhou X; Secrist JP; Cordon-Cardo C; Kelly WK; Drobnjak M; Marks PA
    Methods Enzymol; 2004; 376():199-205. PubMed ID: 14975307
    [No Abstract]   [Full Text] [Related]  

  • 38. Optimization of a series of potent and selective ketone histone deacetylase inhibitors.
    Pescatore G; Kinzel O; Attenni B; Cecchetti O; Fiore F; Fonsi M; Rowley M; Schultz-Fademrecht C; Serafini S; Steinkühler C; Jones P
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5528-32. PubMed ID: 18809328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and Synthesis of Novel Anti-Plasmodial Histone Deacetylase Inhibitors Containing an Alkoxyamide Connecting Unit.
    Alves Avelar LA; Held J; Engel JA; Sureechatchaiyan P; Hansen FK; Hamacher A; Kassack MU; Mordmüller B; Andrews KT; Kurz T
    Arch Pharm (Weinheim); 2017 Apr; 350(3-4):. PubMed ID: 28317157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sulfamides as novel histone deacetylase inhibitors.
    Wahhab A; Smil D; Ajamian A; Allan M; Chantigny Y; Therrien E; Nguyen N; Manku S; Leit S; Rahil J; Petschner AJ; Lu AH; Nicolescu A; Lefebvre S; Montcalm S; Fournel M; Yan TP; Li Z; Besterman JM; Déziel R
    Bioorg Med Chem Lett; 2009 Jan; 19(2):336-40. PubMed ID: 19084395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.